Evidence map›Paper›PMID 40021637›Full record

ArticleNature communications2025

Unraveling the molecular basis of substrate specificity and halogen activation in vanadium-dependent haloperoxidases.

P Zeides, K Bellmann-Sickert, Ru Zhang, C J Seel, V Most, C T Schoeder, M Groll, T Gulder

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Peptide halogenation biochemistry: interfacing pharmaceutical deliverables with chemical innovation.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2025
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

P Zeides *Biomimetic Catalysis, Catalysis Research Center, TUM School of Natural Sciences, Technical University of Munich, Garching, Germany.
K Bellmann-Sickert *Faculty of Chemistry and Mineralogy, Institute of Organic Chemistry, Leipzig University, Leipzig, Germany.
Ru ZhangFaculty of Chemistry and Mineralogy, Institute of Organic Chemistry, Leipzig University, Leipzig, Germany.
C J SeelBiomimetic Catalysis, Catalysis Research Center, TUM School of Natural Sciences, Technical University of Munich, Garching, Germany.
V MostFaculty of Medicine, Institute for Drug Discovery, Leipzig University, Leipzig, Germany.ORCID http://orcid.org/0000-0002-2263-4608
C T SchoederFaculty of Medicine, Institute for Drug Discovery, Leipzig University, Leipzig, Germany.
M GrollDepartment of Bioscience, Center for Protein Assemblies, TUM School of Natural Sciences, Technical University of Munich, Garching, Germany.ORCID http://orcid.org/0000-0002-1660-340X
T GulderBiomimetic Catalysis, Catalysis Research Center, TUM School of Natural Sciences, Technical University of Munich, Garching, Germany. tanja.gulder@uni-saarland.de.ORCID http://orcid.org/0000-0003-4870-2266

Funding

Deutsche Bundesstiftung Umwelt (German Federal Environmental Foundation) 20015/400Deutsche Forschungsgemeinschaft (German Research Foundation) GU 1134/3-1Deutsche Forschungsgemeinschaft (German Research Foundation) GU 1134/4-1
6 · The paper itself

Abstract

Vanadium-dependent haloperoxidases (VHPOs) are biotechnologically valuable and operationally versatile biocatalysts. VHPOs share remarkable active-site structural similarities yet display variable reactivity and selectivity. The factors dictating substrate specificity and, thus, a general understanding of VHPO reaction control still need to be discovered. This work's strategic single-point mutation in the cyanobacterial bromoperoxidase AmVHPO facilitates a selectivity switch to allow aryl chlorination. This mutation induces loop formation that interacts with the neighboring protein monomer, creating a tunnel to the active sites. Structural analysis of the substrate-R425S-mutant complex reveals a substrate-binding site at the interface of two adjacent units. There, residues Glu139 and Phe401 interact with arenes, extending the substrate residence time close to the vanadate cofactor and stabilizing intermediates. Our findings validate the long-debated existence of direct substrate binding and provide a detailed VHPO mechanistic understanding. This work will pave the way for a broader application of VHPOs in diverse chemical processes.

Indexed as

Bacterial ProteinsHalogensPeroxidasesVanadiumBinding SitesCatalytic DomainCrystallography, X-RayCyanobacteriaHalogenationModels, MolecularSubstrate SpecificityBacterial Proteinsbromide peroxidaseHalogensPeroxidasesVanadium

Identifiers

PMID40021637
PMCPMC11871015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.